American pharmaceutical Gilead Sciences is in talks with chemical and drug makers to produce its experimental drug remdesivir, a potential coronavirus treatment
More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences